(c) 2022 PillSync.com

acetaminophen caffeine dihydrocodeine bitartrate capsule

INDICATIONS AND USAGE: Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate capsules are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see WARNINGS ], reserve Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] Have not been tolerated, or are not expected to be tolerated, Have not provided adequate analgesia, or are not expected to provide adequate analgesia

xspire pharma, llc


2 years ago CAPSULE RED Trezix acetaminophen caffeine dihydrocodeine bitartrate capsule

CAPSULE RED Trezix

HOW SUPPLIED: Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate capsules, containing Acetaminophen 320.5 mg, caffeine 30 mg and dihydrocodeine bitartrate 16 mg, are supplied in bottles of 100 capsules (NDC # 42195-840-10) and 30 capsules (NDC # 42195-840-30). Capsules are imprinted “TREZIX” on the red cap in white ink. Store at 20°C to 25°C (68°F to 77°F). [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container with a child-resistant closure. Protect from moisture. Rx Only Manufactured for: Xspire Pharma LLC Ridgeland, MS 39157 13001 Rev. 7/2017 Physician’s Desk Reference ® is the registered trademark of Thomson Healthcare, Inc.

More pills like CAPSULE Trezix












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site